Insights Into Participating in Studies for Bone Cancer

Launched by POWER LIFE SCIENCES INC. · Sep 30, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Insights Into Participating in Studies for Bone Cancer," is focused on understanding how well patients with bone cancer complete the study and why some may choose to withdraw. Researchers want to find out if new treatments for bone cancer are more effective and safe compared to the standard therapies currently available. By gathering this information, they hope to improve future treatments for patients.

To be eligible for this trial, participants need to be at least 18 years old and should have a diagnosis of bone cancer without having received any prior treatments for it. Participants will need to provide their written consent to join the study. It's important to note that individuals with certain mental health issues or those already enrolled in other research studies may not be able to participate. Although the trial is not yet recruiting, it aims to gather valuable insights that could lead to better care for those affected by bone cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• • Diagnosis of bone cancer
• • No prior treatment for bone cancer
• Exclusion Criteria:
• • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
• • Enrolled in another research study
• • Inability to provide written informed consent